Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
McKinsey
Colorcon
Mallinckrodt
McKesson

Last Updated: December 6, 2022

CLINICAL TRIALS PROFILE FOR FLUORODOPA F-18


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Fluorodopa F-18

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00674440 ↗ Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism Completed University of Pennsylvania Phase 2 2004-12-01 Children with congenital hyperinsulinism (CHI) have low blood sugar, and some of these children may require surgery. In this study, researchers affiliated with the University of Pennsylvania will test how well a radioactive drug (called F-DOPA) can detect a form of hyperinsulinism that may be cured by surgery. Eligible participants in this study will have positron emission tomography (PET) scans with F-DOPA prior to surgery.
NCT00674440 ↗ Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism Completed Children's Hospital of Philadelphia Phase 2 2004-12-01 Children with congenital hyperinsulinism (CHI) have low blood sugar, and some of these children may require surgery. In this study, researchers affiliated with the University of Pennsylvania will test how well a radioactive drug (called F-DOPA) can detect a form of hyperinsulinism that may be cured by surgery. Eligible participants in this study will have positron emission tomography (PET) scans with F-DOPA prior to surgery.
NCT01165632 ↗ Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma Active, not recruiting National Cancer Institute (NCI) Early Phase 1 2010-07-26 RATIONALE: New imaging procedures, such as fluorine F 18 fluorodopa-labeled PET scan, may help in guiding surgery and radiation therapy and allow doctors to plan better treatment. PURPOSE: This clinical trial studies fluorine F 18 fluorodopa-labeled PET scan in planning surgery and radiation therapy in treating patients with newly diagnosed high- or low-grade malignant glioma
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Fluorodopa F-18

Condition Name

Condition Name for Fluorodopa F-18
Intervention Trials
Malignant Glioma 4
Adult Anaplastic Oligodendroglioma 2
Adult Pineal Gland Astrocytoma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Fluorodopa F-18
Intervention Trials
Glioma 7
Glioblastoma 4
Parkinson Disease 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Fluorodopa F-18

Trials by Country

Trials by Country for Fluorodopa F-18
Location Trials
United States 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Fluorodopa F-18
Location Trials
Minnesota 4
Pennsylvania 3
Texas 2
Arizona 1
Missouri 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Fluorodopa F-18

Clinical Trial Phase

Clinical Trial Phase for Fluorodopa F-18
Clinical Trial Phase Trials
Phase 2 5
Phase 1 3
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Fluorodopa F-18
Clinical Trial Phase Trials
Active, not recruiting 4
Terminated 3
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Fluorodopa F-18

Sponsor Name

Sponsor Name for Fluorodopa F-18
Sponsor Trials
National Cancer Institute (NCI) 5
Mayo Clinic 4
The Methodist Hospital Research Institute 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Fluorodopa F-18
Sponsor Trials
Other 14
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Express Scripts
McKesson
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.